AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2014
Sep 26, 2014
32566_dirs_2014-09-26_c091e057-b25f-47e5-81d3-b2fd06d5bc6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-09-24
Reporting Person: Evans James S (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-24 | Common Stock | M | 8790.0 | $30.12 | Acquired | 56918 | Direct |
| 2014-09-24 | Common Stock | S | 8790.0 | $37.98 | Disposed | 48128 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-24 | Non-Qualified Stock Option (right to buy) | $30.12 | M | 8790.0 | Disposed | 2019-02-18 | Common Stock (8790) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2